Anavex Life Sciences
AVXL
#9983
Rank
A$0.11 B
Marketcap
A$1.21
Share price
-12.42%
Change (1 day)
-77.86%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -A$19.48 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$59.36 Million, an increase over its 2024 earnings that were of -A$76.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$19.48 Million-67.19%
2025 -A$59.36 Million-22.43%
2024 -A$76.51 Million14.77%
2023 -A$66.67 Million-17.49%
2022 -A$80.8 Million22.96%
2021 -A$65.71 Million35.36%
2020 -A$48.55 Million12.65%
2019 -A$43.1 Million29.09%
2018 -A$33.38 Million36.33%
2017 -A$24.49 Million17.11%
2016 -A$20.91 Million20.91%
2015 -A$17.3 Million-6.29%
2014 -A$18.46 Million337.28%
2013 -A$4.23 Million
2008 -A$7.81 Million106.01%
2007 -A$3.79 Million8848.98%
2006 -A$0.05 Million-79.99%
2005 -A$0.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
A$90.39 M-570.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$0.16 B-956.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$12.43 Million-35.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$0.53 Billion 2,638.61%๐Ÿ‡บ๐Ÿ‡ธ USA